Riparian Pharmaceuticals Riparian Pharmaceuticals is a biotechnology company engaged in discovering therapeutics to promote vascular health. | ![]() Albireo Pharma Albireo, a biotechnology company, develops therapeutic drugs for gastrointestinal diseases. | ICB International ICB International (ICBI) is a company that provides disease altering therapies for afflictions of the central nervous system. | ![]() Albumedix Albumedix develops bio-therapeutics formulations for advanced drug and vaccine formulation intended to improve therapies for people with serious diseases. | |
Founding Date | Founding Date 2012 | Founding Date 2003 | Founding Date 2008 | Founding Date 2016 |
Type | Type Private | Type Public | Type Private | Type Private |
Tags | ||||
Locations | Locations Watertown, US HQ | Locations Boston, US HQ Göteborg, SE | Locations San Diego, US HQ | Locations Nottinghamshire, GB HQ Nottingham, GB |
Employees | Employees 233% decrease | Employees 5541% increase | Employees 11 | Employees 871% increase |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $40.6m (FY, 2021) | Revenue (est.) N/A | Revenue (est.) £26.1m (FY, 2018) |
Net income | Net income N/A | Net income ($34m) (FY, 2021) | Net income N/A | Net income £5m (FY, 2018) |
Funding | ||||
Latest funding round | Latest funding round $ 500k (almost 8 years ago) | Latest funding round N/A | Latest funding round $ 895k (about 13 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 3.5m | Total funding raised $ 40m | Total funding raised N/A | Total funding raised N/A |

Albireo, a biotechnology company, develops therapeutic drugs for gastrointestinal diseases.
View companyICB International (ICBI) is a company that provides disease altering therapies for afflictions of the central nervous system.
View company
Albumedix develops bio-therapeutics formulations for advanced drug and vaccine formulation intended to improve therapies for people with serious diseases.
View company